Review
Novel camptothecin derivatives
Affiliations
- PMID: 15796188
Item in Clipboard
Review
Novel camptothecin derivatives
In Vivo.
2005 Jan-Feb.
Free article
Abstract
Efforts continue to be made in the field of oncology to find new and effective chemotherapeutic agents against cancer. From these efforts the camptothecins have emerged as a promising group of agents. Camptothecin, first discovered in 1958, was found to be an effective anti-chemotherapeutic agent, but the toxicities were too great to be used in a clinical setting. Derivatives of the original camptothecin molecule have been created by modifying one or more rings in an effort to improve the pharmacokinetics and toxicity profiles of the parent compound. This article reviews both the in vivo and in vitro characteristics of these novel agents.
Similar articles
-
Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?Drug Resist Updat. 2001 Aug;4(4):273-88. doi: 10.1054/drup.2001.0222. Drug Resist Updat. 2001. PMID: 11998845 Review.
-
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.Clin Cancer Res. 2002 Mar;8(3):641-61. Clin Cancer Res. 2002. PMID: 11895891 Review.
-
Cellular, pharmacokinetic, and pharmacodynamic aspects of response to camptothecins: can we improve it?Drug Resist Updat. 2001 Jun;4(3):152-67. doi: 10.1054/drup.2001.0198. Drug Resist Updat. 2001. Corrected and republished in: Drug Resist Updat. 2001 Aug;4(4):273-88. doi: 10.1054/drup.2001.0222. PMID: 11768329 Corrected and republished. Review.
-
Preclinical to clinical development of the novel camptothecin nanopharmaceutical CRLX101.J Control Release. 2011 Jul 15;153(1):49-55. doi: 10.1016/j.jconrel.2011.03.007. Epub 2011 Mar 23. J Control Release. 2011. PMID: 21406204
-
Synthesis and antitumor activity of novel 10-substituted camptothecin analogues.Bioorg Med Chem. 2006 Nov 1;14(21):7175-82. doi: 10.1016/j.bmc.2006.06.061. Epub 2006 Jul 25. Bioorg Med Chem. 2006. PMID: 16870453
Cited by
-
Camptothecin (CPT) and its derivatives are known to target topoisomerase I (Top1) as their mechanism of action: did we miss something in CPT analogue molecular targets for treating human disease such as cancer?Am J Cancer Res. 2017 Dec 1;7(12):2350-2394. eCollection 2017. Am J Cancer Res. 2017. PMID: 29312794 Free PMC article. Review.
-
Dual action of NSC606985 on cell growth and apoptosis mediated through PKCδ in prostatic cancer cells.Int J Oncol. 2017 Nov;51(5):1601-1610. doi: 10.3892/ijo.2017.4138. Epub 2017 Sep 27. Int J Oncol. 2017. PMID: 29048618 Free PMC article.
-
A novel approach for organelle-specific DNA damage targeting reveals different susceptibility of mitochondrial DNA to the anticancer drugs camptothecin and topotecan.Nucleic Acids Res. 2009 Mar;37(4):e26. doi: 10.1093/nar/gkn1087. Epub 2009 Jan 16. Nucleic Acids Res. 2009. PMID: 19151088 Free PMC article.
-
Research Progress of SN38 Drug Delivery System in Cancer Treatment.Int J Nanomedicine. 2024 Jan 26;19:945-964. doi: 10.2147/IJN.S435407. eCollection 2024. Int J Nanomedicine. 2024. PMID: 38293612 Free PMC article. Review.
-
The Advancement of Biodegradable Polyesters as Delivery Systems for Camptothecin and Its Analogues-A Status Report.Int J Mol Sci. 2023 Jan 5;24(2):1053. doi: 10.3390/ijms24021053. Int J Mol Sci. 2023. PMID: 36674567 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
